Halaman 1 dari 23 hasil
TECHNICAL FIELD
The present invention relates to the treatment of female menstrual disorders. More specifically, the present invention relates to the pharmacological treatment of menstrual pain accompanied with excessive menstrual blood loss. Further, the present invention relates to the
TECHNICAL FIELD
The present invention relates to the treatment of female menstrual disorders. More specifically, the present invention relates to the pharmacological treatment of menstrual pain accompanied with excessive menstrual blood loss. Further, the present invention relates to the
FIELD OF INVENTION
The invention is directed to methods for diagnosing reperfusion and non-reperfusion hemorrhage, predicting cardiac arrhythmias, sudden cardiac death, and adverse remodeling in subjects post myocardial infarction. The invention also provides treatment methods for subjects at
FIELD OF THE INVENTION
This invention generally relates to compounds, compositions, and methods for preventing and treating diseases such as intracerebral hemorrhage, cancer or conditions associated with damaged cells, activated lymphocytes, or microbial products. The compounds are curcumin
CROSS REFERENCE TO RELATED APPLICATIONS
N/A
BACKGROUND OF THE INVENTION
A necessary function of the intestinal epithelium is the establishment of a selective barrier to allow the absorption of nutrients while restricting the uptake of toxic substances and microbes from the gut lumen. A major
BACKGROUND OF THE INVENTION
The present invention relates to the use of quaternary N-benzyl-N-{2-[2-((1S,5S)-6,6-dimethylbicyclo[3,1,1]hept-2-yl)-ethoxy]-eth yl}-morpholinium salts for the prophylaxis and treatment of blood circulation disorders in the peripheral, in particular in the microvascular,
FIELD OF THE INVENTION
This invention relates to pharmaceutical compositions of the d,l- or l-lysine salt of R,S or S-ibuprofen having analgesic, anti-inflammatory and anti-pyretic activity. The invention further relates to a method of treating pain or inflammation or of reducing fever by
BACKGROUND
A wide variety of compositions and devices have been developed for use in controlling bleeding. However, available compositions and dressings typically have only a modest hemostatic effect, so that bleeding continues for several (e.g., 2-3 minutes or more) after application of composition
BACKGROUND
A wide variety of compositions and devices have been developed for use in controlling bleeding. However, available compositions and dressings typically have only a modest hemostatic effect, so that bleeding continues for several (e.g., 2-3 minutes or more) after application of composition
FIELD OF THE INVENTION
The invention relates to novel compositions and process for preparation of such compositions comprising an extract of the plant Euphorbia prostrata useful for the treatment of anorectal diseases including hemorrhoids, and colonic diseases. The novel compositions possess
FIELD OF THE INVENTION
The present invention relates to 7-[carboxyalkyl or alkenyl]-6-[alkyl or alkenyl]-3-oxo-2,4-dioxobicyclo[3.2.1]octanes and derivatives thereof. In particular, hydroxyl, nitro, amino, amido, azido, oxime, thiol, ether and thiol ether derivatives of said carboxy group are
FIELD OF THE INVENTION
The present invention relates to 7-[carboxyalkyl or alkenyl]-6-[alkyl or alkenyl]-3-oxo-2,4-dioxobicyclo[3.2.1 ] octanes and derivatives thereof. In particular, hydroxyl, nitro, amino, amido, azido, oxime, thiol, ether and thiol ether derivatives of said carboxy group are
BACKGROUND OF THE INVENTION
1. Field of the Invention
The decrease or reduction of toxicity, and the inhibition of ulcerogenesis and bleeding in the stomach, due to the ingestion of a pharmaceutically effective concentration or dosage of aspirin.
2. Description of the Prior Art
The extensive use of
FIELD OF THE INVENTION
The present invention is directed to pharmaceutical compositions that provide for the coordinated release of an acid inhibitor and a non-steroidal anti-inflammatory drug (NSAID). These compositions have a reduced likelihood of causing unwanted side effects, especially
FIELD OF THE INVENTION
The present invention is directed to pharmaceutical compositions that provide for the coordinated release of an acid inhibitor and a non-steroidal anti-inflammatory drug (NSAID). These compositions; have a reduced likelihood of causing unwanted side effects, especially